FDA Inspection 1157261 — IVI RMA of New Jersey
The FDA completed an inspection of IVI RMA of New Jersey on October 28, 2021 in Marlton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 28, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Marlton, NJ (United States)